FDAnews Announces FDA Under the Biden Administration: What’s to Come and What It Will Mean Webinar Feb. 10, 2021

Share Article

Ready for the changes coming to the FDA? Prepare now for the shifts the Biden administration will bring. Register for this webinar.

WCG FDAnews

WCG FDAnews

FDA Under the Biden Administration:
What’s to Come and What It Will Mean
An FDAnews Webinar
Wednesday, Feb.10, 2021, 1:30 p.m. – 3:30 p.m. EST
https://www.fdanews.com/fdaunderbiden

Changes are coming to the FDA. With the Biden administration, there will be a new commissioner and a likely shift in the agency’s approach. Does one know what will be required now for new product approvals? Does one’s team understand the changes that will come to the inspection process? Does one have a plan for how the FDA will play a role in drug pricing and user-fee programs?    

To successfully move drugs or devices forward, one needs to learn how to maneuver through these adjustments with the clearest understanding of these updated policies and procedures possible.

FDA experts — Wayne L. Pines, President, Health Care, APCO Worldwide — Marc Scheineson, Partner, Alston & Bird LLP — Esther Krofah, Executive Director, FasterCures — Lowell Schiller, Chief Legal and Regulatory Officer, Aetion; Former Principal Associate Commissioner for Policy and Acting Chief Counsel, FDA — will share the changes they expect to see from the agency’s administrative shift. They will also provide guidance on what attendees can do to navigate these shifts head-on and successfully gain approval for products in development.

During this webinar, they’ll cover:

  • What changes are expected at the FDA with the new administration
  • Policies and programs organizations should consider implementing
  • Day-to-day adjustments that could help your team navigate the changes
  • Expert insights into shifts around drug and device regulation, enforcement, drug pricing and health care innovation
  • Specific, practical guidance for preparing for FDA changes
  • Considerations around user fees and the user-fee legislative process

Policies and processes at the FDA may be shifting with the Biden administration but one can prepare for whatever comes one’s way. With this webinar, learn what experts foresee in the coming months and years — and discover how to meet those challenges.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:
FDA Under the Biden Administration:
What’s to Come and What It Will Mean
An FDAnews Webinar
Wednesday, Feb.10, 2021, 1:30 p.m. – 3:30 p.m. EST
https://www.fdanews.com/fdaunderbiden

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/fdaunderbiden
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDAnews
703.538.7600
Email >
Visit website